Patents by Inventor Nigel Grinter

Nigel Grinter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9651305
    Abstract: System and method for lyophilization or freeze-drying is provided. During the freezing step, the material or solution to be frozen is initially brought to a temperature near or below its freezing temperature after which the pressure in the freeze-dryer chamber is reduced to induce nucleation of the material.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: May 16, 2017
    Assignee: SP Industries, Inc.
    Inventors: Theodore Hall Gasteyer, Robert Rex Sever, Balazs Hunek, Nigel Grinter, Melinda Lee Verdone
  • Patent number: 9453675
    Abstract: Methods of inducing nucleation of a material is provided. The disclosed methods comprise the steps of bringing the material to a temperature near or below a phase transition temperature and altering the pressure to induce nucleation of the material. The disclosed methods are useful in freeze-drying processes, particularly pharmaceutical freeze-drying processes.
    Type: Grant
    Filed: February 5, 2007
    Date of Patent: September 27, 2016
    Assignee: SP Industries, Inc.
    Inventors: Theodore Hall Gasteyer, III, Robert Rex Sever, Balazs Hunek, Nigel Grinter, Melinda Lee Verdone
  • Publication number: 20160169579
    Abstract: System and method for lyophilization or freeze-drying is provided. During the freezing step, the material or solution to be frozen is initially brought to a temperature near or below its freezing temperature after which the pressure in the freeze-dryer chamber is reduced to induce nucleation of the material.
    Type: Application
    Filed: November 17, 2015
    Publication date: June 16, 2016
    Inventors: Theodore Hall Gasteyer, Robert Rex Sever, Balazs Hunek, Nigel Grinter, Melinda Lee Verdone
  • Patent number: 9200836
    Abstract: System and method for lyophilization or freeze-drying is provided. During the freezing step, the material or solution to be frozen is initially brought to a temperature near or below its freezing temperature after which the pressure in the freeze-dryer chamber is reduced to induce nucleation of the material.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: December 1, 2015
    Assignee: SP INDUSTRIES, INC.
    Inventors: Theodore Hall Gasteyer, III, Robert Rex Sever, Balazs Hunek, Nigel Grinter, Melinda Lee Verdone
  • Patent number: 9181521
    Abstract: A bioreactor with an upward flowing impeller system for controlling a mammalian cell culture process is provided. The disclosed system enables control of the cell culture process by controlling the level of dissolved carbon dioxide in the cell culture media and prevent increases in the osmolality level is achieved by enhanced stripping of carbon dioxide via surface gas exchange with little or no damage to the mammalian cells. The use of an upward flow impeller combined with vertical baffles converts the swirling motions of the cell culture media into a largely vertical flow and promotes the removal of dissolved carbon dioxide via surface gas exchange with a sweep gas flowing over the top surface of the cell culture media within the bioreactor vessel.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: November 10, 2015
    Assignee: PRAXAIR TECHNOLOGY, INC.
    Inventors: Alan T. Y. Cheng, Ying Zhou, Amitabh Gupta, Balazs Hunek, Nigel Grinter
  • Patent number: 8956566
    Abstract: Methods and systems for virus inactivation in the production or processing of biological or other sensitive substances are provided. The disclosed methods and systems for virus inactivation involve the key steps of dissolving carbon dioxide into biological or other sensitive substances; and treating the substance with the dissolved carbon dioxide at conditions which are less than critical pressure and temperature for a prescribed treatment time to inactivate at least 80% of the target virus or viruses contained within the biological or other sensitive substances. The disclosed carbon dioxide treatments for virus inactivation may optionally include concurrently or sequentially subjecting the substances with an acid treatment to lower the pH of the substance and inactivate viruses contained within the biological or other sensitive substance.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: February 17, 2015
    Assignee: Pure Biosolutions, LLC
    Inventors: Peter W. Latham, Nigel Grinter, Robert Sever
  • Publication number: 20140325868
    Abstract: System and method for lyophilization or freeze-drying is provided. During the freezing step, the material or solution to be frozen is initially brought to a temperature near or below its freezing temperature after which the pressure in the freeze-dryer chamber is reduced to induce nucleation of the material.
    Type: Application
    Filed: July 18, 2014
    Publication date: November 6, 2014
    Inventors: Theodore Hall Gasteyer, III, Robert Rex Sever, Balazs Hunek, Nigel Grinter, Melinda Lee Verdone
  • Patent number: 8793895
    Abstract: System and method for lyophilization or freeze-drying is provided. During the freezing step, the material or solution to be frozen is initially brought to a temperature near or below its freezing temperature after which the pressure in the freeze-dryer chamber is reduced to induce nucleation of the material.
    Type: Grant
    Filed: February 5, 2007
    Date of Patent: August 5, 2014
    Assignee: Praxair Technology, Inc.
    Inventors: Theodore Hall Gasteyer, III, Robert Rex Sever, Balazs Hunek, Nigel Grinter, Melinda Lee Verdone
  • Publication number: 20140047851
    Abstract: A system and method for bulk freezing is provided. In one embodiment, the system and method for bulk freezing includes a bulk freezing container adapted to hold at least one and preferably a plurality of bags holding a biopharmaceutical liquid. The bulk freezing container includes at least a first and second shelf having corrugations wherein the second shelf is vertically arranged above the first shelf with the bags disposed between the shelves. The bags and the corrugations of the first and second shelves define a plurality of substantially parallel flow channels through which a cryogenic cold fluid or a warming fluid is passed to freeze and/or thaw the biopharmaceutical fluid. In another embodiment, the bulk freezing system and method includes a bulk freezing container with a plurality of adjacent elongated chambers adapted for holding the biopharmaceutical fluid.
    Type: Application
    Filed: March 27, 2012
    Publication date: February 20, 2014
    Applicant: PRAXAIR TECHNOLOGY, INC.
    Inventors: Ying Zhou, Alan Cheng, Nigel Grinter, Zachary Fowler, Robert Sever, Ranko Bursac
  • Publication number: 20130236358
    Abstract: Methods and systems for virus inactivation in the production or processing of biological or other sensitive substances are provided. The disclosed methods and systems for virus inactivation involve the key steps of dissolving carbon dioxide into biological or other sensitive substances; and treating the substance with the dissolved carbon dioxide at conditions which are less than critical pressure and temperature for a prescribed treatment time to inactivate at least 80% of the target virus or viruses contained within the biological or other sensitive substances. The disclosed carbon dioxide treatments for virus inactivation may optionally include concurrently or sequentially subjecting the substances with an acid treatment to lower the pH of the substance and inactivate viruses contained within the biological or other sensitive substance.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 12, 2013
    Inventors: Peter W. Latham, Nigel Grinter, Robert Sever
  • Publication number: 20130189767
    Abstract: A bioreactor with an upward flowing impeller system for controlling a mammalian cell culture process is provided. The disclosed system enables control of the cell culture process by controlling the level of dissolved carbon dioxide in the cell culture media and prevent increases in the osmolality level is achieved by enhanced stripping of carbon dioxide via surface gas exchange with little or no damage to the mammalian cells. The use of an upward flow impeller combined with vertical baffles converts the swirling motions of the cell culture media into a largely vertical flow and promotes the removal of dissolved carbon dioxide via surface gas exchange with a sweep gas flowing over the top surface of the cell culture media within the bioreactor vessel.
    Type: Application
    Filed: July 27, 2012
    Publication date: July 25, 2013
    Inventors: Alan T. Y. Cheng, Ying Zhou, Amitabh Gupta, Balazs Hunek, Nigel Grinter
  • Patent number: 8241904
    Abstract: A system and method for controlling a mammalian cell culture process are provided. Such control of the cell culture process involves control of the level of dissolved carbon dioxide in the cell culture media and the resulting ability to prevent increases in the osmolality level is achieved by enhanced stripping of carbon dioxide with little or no damage to the mammalian cells. The disclosed methods and systems of dissolved carbon dioxide stripping include enhanced surface gas exchange mechanisms within the bioreactor vessel through the use of an upward flow impeller combined with vertical baffles to convert swirling motions of the liquid into a largely vertical flow.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: August 14, 2012
    Assignee: Praxair Technology, Inc.
    Inventors: Alan T. Y. Cheng, Ying Zhou, Balazs Hunek, Amitabh Gupta, Nigel Grinter
  • Patent number: 8178318
    Abstract: Methods for controlling the level of dissolved carbon dioxide and limiting osmolality in a mammalian cell culture process to enhance cell growth, viability and density, and increase biologic product concentration and yield are provided. Such control of the level of dissolved carbon dioxide and pH as well as the resulting ability to limit osmolality in a mammalian cell culture process is achieved by adopting alternative pH control strategies and CO2 stripping techniques during a mammalian cell culture process. Such pH control techniques and carbon dioxide stripping occur without foam and with little or no damage to the mammalian cells.
    Type: Grant
    Filed: February 9, 2010
    Date of Patent: May 15, 2012
    Assignee: Praxair Technology, Inc.
    Inventors: Alan T. Y. Cheng, Ying Zhou, Amitabh Gupta, Balazs Hunek, Nigel Grinter
  • Publication number: 20100184147
    Abstract: Methods for controlling the level of dissolved carbon dioxide and limiting osmolality in a mammalian cell culture process to enhance cell growth, viability and density, and increase biologic product concentration and yield are provided. Such control of the level of dissolved carbon dioxide and pH as well as the resulting ability to limit osmolality in a mammalian cell culture process is achieved by adopting alternative pH control strategies and CO2 stripping techniques during a mammalian cell culture process. Such pH control techniques and carbon dioxide stripping occur without foam and with little or no damage to the mammalian cells.
    Type: Application
    Filed: February 9, 2010
    Publication date: July 22, 2010
    Inventors: ALAN T.Y. CHENG, Ying Zhou, Amitabh Gupta, Balazs Hunek, Nigel Grinter
  • Publication number: 20100035342
    Abstract: Methods for controlling the level of dissolved carbon dioxide and limiting osmolality in a mammalian cell culture process to enhance cell growth, viability and density, and increase biologic product concentration and yield are provided. Such control of the level of dissolved carbon dioxide and pH as well as the resulting ability to limit osmolality in a mammalian cell culture process is achieved by adopting alternative pH control strategies and CO2 stripping techniques during a mammalian cell culture process. Such pH control techniques and carbon dioxide stripping occur with little or no damage to the mammalian cells.
    Type: Application
    Filed: August 6, 2009
    Publication date: February 11, 2010
    Inventors: ALAN T.Y. CHENG, YING ZHOU, AMITABH GUPTA, BALAZS HUNEK, NIGEL GRINTER
  • Publication number: 20100035343
    Abstract: A system and method for controlling a mammalian cell culture process are provided. Such control of the cell culture process involves control of the level of dissolved carbon dioxide in the cell culture media and the resulting ability to prevent increases in the osmolality level is achieved by enhanced stripping of carbon dioxide with little or no damage to the mammalian cells. The disclosed methods and systems of dissolved carbon dioxide stripping include enhanced surface gas exchange mechanisms within the bioreactor vessel through the use of an upward flow impeller combined with vertical baffles to convert swirling motions of the liquid into a largely vertical flow.
    Type: Application
    Filed: August 6, 2009
    Publication date: February 11, 2010
    Inventors: Alan T.Y. Cheng, Ying Zhou, Balazs Hunek, Amitabh Gupta, Nigel Grinter
  • Patent number: 7560232
    Abstract: Methods for specific RNA capture, detection and quantification are presented utilizing a protein that selectively binds RNA:DNA hybrids, preferably an RNase H that is modified to reduce degradation of the nucleic acid molecules and enhance specific detection of mixed RNA:DNA nucleic acid hybrids. Labeling of the RNA and/or amplification is not required to perform these methods. Modified RNase H enzymes useful in such methods are disclosed.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: July 14, 2009
    Assignee: Promega Corporation
    Inventors: Richard Carter, Martin Rosenburg, Daniel R. Gentry, Nigel Grinter
  • Publication number: 20090001042
    Abstract: A container closure system for use in lyophilization processes employing depressurization to initiate nucleation is provided. The present container closure system includes a container and a closure element disposed proximate to and adapted for sealing the opening of the container. The closure element includes a first sealing surface adapted for sealably contacting an interior surface of the container and a second sealing surface adapted for sealably contacting the top surface of the container when the container closure system is in a closed position. The closure element also includes a plurality of closure legs extending from the second sealing surface that define a plurality of side vents between each of the closure legs when the container closure system is in the open position. The length, thickness, number, and shape of the legs are chosen to produce an effective total side vent area that is at least 50% of the area of the container opening.
    Type: Application
    Filed: June 24, 2008
    Publication date: January 1, 2009
    Inventors: Robert Sever, Balazs Hunek, Nigel Grinter, Gurjit Baring
  • Publication number: 20070186567
    Abstract: Methods of inducing nucleation of a material is provided. The disclosed methods comprise the steps of bringing the material to a temperature near or below a phase transition temperature and altering the pressure to induce nucleation of the material. The disclosed methods are useful in freeze-drying processes, particularly pharmaceutical freeze-drying processes.
    Type: Application
    Filed: February 5, 2007
    Publication date: August 16, 2007
    Inventors: Theodore Hall Gasteyer, Robert Rex Sever, Balazs Hunek, Nigel Grinter, Melinda Lee Verdone
  • Publication number: 20070186437
    Abstract: System and method for lyophilization or freeze-drying is provided. During the freezing step, the material or solution to be frozen is initially brought to a temperature near or below its freezing temperature after which the pressure in the freeze-dryer chamber is reduced to induce nucleation of the material.
    Type: Application
    Filed: February 5, 2007
    Publication date: August 16, 2007
    Inventors: Theodore Hall Gasteyer, Robert Rex Sever, Balazs Hunek, Nigel Grinter, Melinda Lee Verdone